PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

47 hedge funds and large institutions have $159M invested in Protalix BioTherapeutics in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 7 closing their positions.

Holders
47
Holders Change
–
Holders Change %
0%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
21
Reduced
11
Closed
7
Calls
$210K
Puts
$3.84M
Net Calls
-$3.63M
Net Calls Change
-$1.91M

Top Buyers

1
Baillie Gifford & Co
1
Baillie Gifford & Co
United Kingdom
$25.1M
2
Allianz Asset Management
2
Allianz Asset Management
Germany
$34.7M
3
BA
3
BlackRock Advisors
Delaware
$9.78M
4
DCM
4
DAFNA Capital Management
California
$5.34M
5
CCM
5
Camber Capital Management
Massachusetts
$8.11M

Top Sellers

1
MNA
1
Manning & Napier Advisors
New York
$0
2
OAM
2
Oberweis Asset Management
Illinois
$246K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$0
5
MMH
5
Menora Mivtachim Holdings
Israel
$4.72M
Name Holding Trade Value Shares
Change 		Shares
Change %
SGAM
51
Smith Group Asset Management
Texas
– -$23K -459 Closed
1 2
3